CVRX INC

Insightful insider buying: COO Brent Binkowski purchases 26k CVRx shares amid a 50% dip, signaling confidence in a rebound via commercial strategy and payer value‑based contracts.

Insider selling at CVRx shows tax‑driven moves amid a 58% YTD drop, yet exec buying signals confidence in its hypertension device pipeline.

Investor insight: Jain Mudit K’s recent CVRx buy signals confidence amid a steep 60% slide, as the VFMS device shows promising Phase‑II results that could spark FDA clearance and a market rebound.